Skip to main content
Clinical Trials/DRKS00008848
DRKS00008848RecruitingPhase 2

Study to compare the effects between the RelaxBogen and its Myo fascial approach with the occlusial splint in TMD and Bruxism therapie - RB2

Zahnarztpraxis0 sites34 target enrollmentStarted: September 16, 2016Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
34

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • N=34 with bruxism and TMD symptomes measured with a Bruxchecker Film and a TMD investigation by the dentist and with scientific questionaire.
  • Each patient needs to have, scince minimum of 3 months, an occlusal splint. An other selection criteria is, that the reason for the TMD and Bruxism is restricted to jaw, neck and shoulder pain.
  • The patients needs to be full aged and need to have no pschological disease.
  • People which suffue from an alcohol- oder drug disease are eccluded too

Exclusion Criteria

  • Exclusion criteria are:
  • The patient is underaged or not able to give one's consent. Used a RelaxBogen before. Is depressive, a drug abuser or takes medicine that could introduce Bruxism. A trauma in the head area or the cervical spine. Planned dental restoration during the period of the study. The main pain perception analysed in the SLNR-questionaire is not located in the area of the head, shoulders or the neck.

Investigators

Sponsor
Zahnarztpraxis

Similar Trials